Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Cornea. 2019 Aug;38(8):933–937. doi: 10.1097/ICO.0000000000001942

Table 1:

Characteristics of participants with bacterial keratitis and medication use

Patient Characteristic (n=48) Frequency (percent)
Sex (female) 27 (56%)
Median (IQR) Mean (SD) Range
Age (years) 49.5 (36, 63) 50.6 (20) 19 – 88
Income (USD) $58,049 ($46703, $78,197) $61,554 ($23,193) $17,667-$113,542
Number of visits per patient 10 (6, 13) 10.6 (5.9) 3 – 27
Length of treatment per patient* (days) 54 (20, 110) 90 (96.5) 9 – 373
Number of unique medications 5 (3, 6) 5.2 (2.6) 1 – 14
Cumulative medication doses 587 (227, 1052) 837.2 (850.1) 48 – 4149
Maximum daily dose 48 (20,51) 39.6 (20.2) 6–96
Average doses per day 8.2 (5.8–12.9) 10.6 (8.0) 2.7–52.7
Number of bottles of medications prescribed per patient 7 (4, 12) 10.5 (11.2) 1 – 49
Wholesale price per patient (USD) $933 ($457, $1422) $1344 ($1607) $10 - $8232

IQR, interquartile range; SD, standard deviation; USD, United States dollars

*

length of treatment defined as length on medications until corneal scar formation